The Pharmaceutical Project
Dicot is in preclinical phase with the drug candidate LIB-01, a modern potency drug to better treat erectile dysfunction and premature ejaculation.
Pharmacology studies
In a research collaboration with reputable Pelvipharm, the effect of the substance and future area of use will be clarified.
Read More >Toxicology program
Toxicology determines the extent of a substance's possible side effects. Read more about Dicot's toxicology program here.
Read More >
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 867137.